Skip to main content
. Author manuscript; available in PMC: 2016 Aug 16.
Published in final edited form as: Leuk Res. 2015 Dec 22;41:43–47. doi: 10.1016/j.leukres.2015.12.007

Fig. 1.

Fig. 1

Overall survival and Leukaemia-free survival based on best response. (A) shows overall survival based on responses criteria. CR = complete remission, HI = hematologic improvement. SD = stabledisease, PD = progressive disease, and PR= partial response. (B) shows time to acute myeloid leukaemia (AML) transformation from start of therapy with hypomethylating agents based on response criteria.